Article
Epigallocatechin-3-Gallate Improves Facial Dysmorphology Associated with Down Syndrome
2018-03-05
Abstract excerpt
In Down syndrome (DS), the overall genetic imbalance caused by trisomy of chromosome 21 leads to a complex pleiotropic phenotype that involves a recognizable set of facial traits. Several studies have shown the potential of epigallocatechin-3-gallate (EGCG), a green tea flavanol, as a therapeutic tool for alleviating different developmental alterations associated with DS, such as cognitive impairment, skull dysmor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- afb0b057-e68c-56dc-8407-e65041d9ab75
- DOI
- 10.1101/276493
